NASDAQ:CMECME Group Stock Price, Forecast & News

CME Group's stock was trading at $194.6750 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CME shares have decreased by 15.5% and is now trading at $164.59. View which stocks have been most impacted by Coronavirus.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 3 sell ratings, 7 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for CME Group.

CME Group is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for CME Group.

CME Group will be holding an earnings conference call on Wednesday, July 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

CME Group Inc (NASDAQ:CME) announced its earnings results on Wednesday, April, 29th. The financial services provider reported $2.33 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $2.23 by $0.10. The financial services provider had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.48 billion. CME Group had a return on equity of 10.15% and a net margin of 45.79%. The firm's revenue was up 29.0% on a year-over-year basis. During the same period last year, the company posted $1.62 EPS. View CME Group's earnings history.

CME Group declared a quarterly dividend on Wednesday, May 6th. Stockholders of record on Wednesday, June 10th will be paid a dividend of $0.85 per share on Thursday, June 25th. This represents a $3.40 dividend on an annualized basis and a yield of 2.07%. The ex-dividend date is Tuesday, June 9th. View CME Group's dividend history.

16 Wall Street analysts have issued 1 year target prices for CME Group's shares. Their forecasts range from $152.00 to $227.00. On average, they expect CME Group's stock price to reach $192.53 in the next year. This suggests a possible upside of 17.0% from the stock's current price. View analysts' price targets for CME Group.

News coverage about CME stock has trended somewhat negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CME Group earned a media sentiment score of -1.8 on InfoTrie's scale. They also assigned media stories about the financial services provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about CME Group.

CME Group saw a drop in short interest in June. As of June 15th, there was short interest totaling 5,480,000 shares, a drop of 6.6% from the May 31st total of 5,870,000 shares. Based on an average daily volume of 2,400,000 shares, the short-interest ratio is currently 2.3 days. Currently, 1.6% of the shares of the stock are short sold. View CME Group's Current Options Chain.

Some companies that are related to CME Group include Moody's (MCO), Intercontinental Exchange (ICE), Msci (MSCI), MarketAxess (MKTX), Interactive Brokers Group (IBKR), Nasdaq (NDAQ), Cboe Global Markets (CBOE), Arrow Financial (AROW), Gain Capital (GCAP), California First National Bancorp (CFNB) and Marlin Business Services (MRLN). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Walt Disney (DIS), Boeing (BA), Mastercard (MA), Visa (V), Alibaba Group (BABA), Paypal (PYPL), Cisco Systems (CSCO), Intel (INTC) and Netflix (NFLX).

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group's stock is owned by a variety of institutional and retail investors. Top institutional investors include Manning & Napier Group LLC (0.10%), Envestnet Asset Management Inc. (0.07%), State of Alaska Department of Revenue (0.03%), Cypress Capital Group (0.02%), Gradient Investments LLC (0.01%) and DNB Asset Management AS (0.01%). Company insiders that own CME Group stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy S Bitsberger and William R Shepard. View institutional ownership trends for CME Group.

CME stock was sold by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., DNB Asset Management AS, Cypress Capital Group, Thomasville National Bank, Orrstown Financial Services Inc., Farmers & Merchants Trust Co of Chambersburg PA, Vigilant Capital Management LLC, and Exane Derivatives. Company insiders that have sold CME Group company stock in the last year include Daniel R Glickman, Dennis Suskind, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy, and Timothy S Bitsberger. View insider buying and selling activity for CME Group.

CME stock was purchased by a variety of institutional investors in the last quarter, including Whittier Trust Co., Park National Corp OH, State of Alaska Department of Revenue, Whittier Trust Co. of Nevada Inc., Platte River Wealth Advisors LLC, Independence Bank of Kentucky, Canandaigua National Corp, and Symphony Financial Ltd. Co.. View insider buying and selling activity for CME Group.

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CME stock can currently be purchased for approximately $164.59.

CME Group has a market capitalization of $59.02 billion and generates $4.87 billion in revenue each year. The financial services provider earns $2.12 billion in net income (profit) each year or $6.80 on an earnings per share basis. CME Group employs 4,360 workers across the globe.

The official website for CME Group is www.cmegroup.com.

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]